BB Biotech AG
- BID
53.8
- ASK
53.8
- 261 Units372 Units
- 07/17, 21:59:02 PM
Sector and Industry
Finance, Investment Services
Performance (1Y)
55.07%
Market Cap
2.94 Bil.
P/E Ratio
4.26
Dividend Yield
5.01 %
Earnings per Share
11.28 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Morgan Stanley | 239.26 Bil. | 106.12 Bil. | 17.39 | +20.74 % | 0.00 | - |
| Goldman Sachs Group Inc | 221.89 Bil. | 111.88 Bil. | 17.13 | +15.36 % | 0.00 | - |
| Citigroup Inc | 173.63 Bil. | 149.94 Bil. | 16.69 | +8.33 % | 0.00 | - |
| Blackstone Inc. | 161.27 Bil. | 12.10 Bil. | 39.83 | +4.26 % | 0.00 | - |
| Charles Schwab Corp. | 149.58 Bil. | 24.53 Bil. | 21.47 | +42.84 % | 0.00 | - |
| Blackrock Inc. | 148.69 Bil. | 22.09 Bil. | 30.31 | -16.40 % | 0.00 | - |
| UBS Group | 122.81 Bil. | 70.13 Bil. | 18.06 | +46.64 % | 0.00 | - |
| KKR & Co. Inc. | 96.76 Bil. | 18.24 Bil. | 54.43 | -26.12 % | 0.00 | - |
| Investor AB ser. B | 93.48 Bil. | 7.58 Bil. | 6.43 | +43.87 % | 0.00 | - |
| Investor AB ser. A | 93.00 Bil. | 7.58 Bil. | 6.39 | +43.87 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 53.9 G | 0 Units |
| PRICE DETERMINATION TIME | 07/17/2026 / 09:55:47 PM | |
| DAILY VOLUME (UNITS) | 140 | |
| DAILY HIGH / LOW | 53.9 | 52.8 |
| PREV. DAY'S PRICE | 53.5 | (07/16) |
| CHANGE DAY BEFORE | +0.40 | 0.75 % |
| 52 WEEK HIGH / LOW | 56.2 (07/07) | 32.6 (08/13) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -3.88 | 1.45 | 11.28 | 2.79 | 2.19 |
DIVIDENDS PER SHARE | 2.06 | 1.89 | 2.41 | 3.26 | 3.26 |
DIVIDEND YIELD IN % | 4.68 % | 5.08 % | 5.01 % | - | - |
DIVIDEND GROWTH IN % | -27.50 % | -8.20 % | 27.28 % | - | - |
PRICE - EARNINGS RATIO | - | 25.57 | 4.26 | 19.42 | 24.80 |
PRICE - BOOK RATIO | 1.01 | 0.85 | 0.89 | - | - |
PRICE - SALES RATIO | - | 31.24 | 32.10 | - | - |
PRICE - CASH FLOW RATIO | 11.04 | 6.48 | 7.98 | - | - |
Master Data
| WKN | A0NFN3 |
| ISIN | CH0038389992 |
| SYMBOL | - |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | BB Biotech |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | Swiss Franc |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Finance, Investment Services |
| NUMBER OF SHARES | 54.90 Mil. |
| MARKET CAPITALISATION | 2.94 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -3.60 % | 14.32 % | 7.11 % | 3.28 % | 55.07 % | - | - | 10.42 % |
| HIGH | 55.90 | 56.20 | 56.20 | 56.20 | 56.20 | - | - | 56.20 |
| LOW | 53.10 | 46.10 | 43.50 | 43.50 | 32.60 | - | - | 43.50 |
Dividende
pro Aktie
Company profile
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
Structured products for BB Biotech AG
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.